Short-term results of a multicenter study based on a modified N7 induction regimen combined with arsenic trioxide in the treatment of children with high-risk neuroblastoma

Objective: To analyze the short-term clinical efficacy and safety of arsenic trioxide (ATO) combined with a modified N7 induction regimen in the treatment of children with high-risk neuroblastoma (NB). Methods: This study was a prospective, single-arm, multicenter phase Ⅱ clinical study. Sixty-seven...

Description complète

Détails bibliographiques

Publié dans:	Zhonghua er ke za zhi = Chinese journal of pediatrics. - 1960. - 62(2024), 10 vom: 02. Okt., Seite 949-955
Auteur principal:	Yang, S (Auteur)
Autres auteurs:	Chen, K L, He, Y Y, Peng, X M, Xiong, H, Jia, W W, Wu, S, Ji, X Q, Chen, Y W, Tian, C, Ye, Z L, Yang, Z, Zhu, J J, Liu, A G, Tian, X H, Pan, F J, Huang, K, Zhou, D H, Fang, J P, Li, Y
Format:	Article en ligne
Langue:	Chinese
Publié:	2024
Accès à la collection:	Zhonghua er ke za zhi = Chinese journal of pediatrics
Sujets:	Journal Article Multicenter Study Clinical Trial, Phase II English Abstract Arsenic Trioxide S7V92P67HO N-Myc Proto-Oncogene Protein MYCN protein, human